Company news

TSO3 Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

TSO3 Appoints Dr. Bradley J. Catalone as Chief Science Officer

September 25, 2017

TSO3 Provides an Update on Recent Activities

September 7, 2017

TSO3 Comments on Unusual Trading Activities

August 23, 2017

TSO3 Reports Record Second Quarter 2017 Results

August 1, 2017

TSO3 Sets Second Quarter Earnings Call for Wednesday, August 2, 2017 at 8: 30 a.m. EDT

July 24, 2017

TSO3 Files for an Extended Claim for Duodenoscopes

July 20, 2017

TSO3 Expands Duodenoscope Regulatory Filing Strategy

June 14, 2017

TSO3 announces the Vote Results from its Annual Meeting of the Shareholders

May 11, 2017

TSO3 Reports Record First Quarter 2017 Results

May 10, 2017

TSO3 to Report First Quarter 2017 Results and Hold Annual Meeting of Shareholders on Wednesday, May 10, 2017

April 26, 2017

TSO3 to publish innovative validation method linked to sterilization of multichannel endoscopes in upcoming issue of the Canadian Journal of Infection Control

April 19, 2017

TSO3 Reports Record Fourth Quarter and Full Year 2016 Results

March 21, 2017

TSO3 Sets Fourth Quarter and Full Year 2016 Earnings Call for Tuesday, March 21, 2017 at 10: 30 a.m. EDT

March 7, 2017

TSO3 Appoints Dr. Linda Rosenstock and Mr. Jeffrey Pompeo to its Board of Directors

February 16, 2017

TSO3 Appoints Mark Pasmore as Vice President of Research and Development

February 2, 2017

TSO3 Welcomes The Medical University of South Carolina to its Strategic Partner Facility Program

January 26, 2017

TSO3 Welcomes The Medical University of South Carolina to its Strategic Partner Facility Program

January 25, 2017

TSO3 Provides an Operational Update

January 5, 2017

TSO3 adds the University of Rochester Medical Center to its Strategic Partner Facility Program

January 5, 2017

TSO3 Enters into Strategic Partner Facility Agreement with The Mount Sinai Hospital

December 23, 2016

TSO3 Secures Access to Non-Dilutive Growth Capital Through Receivables Factoring

December 22, 2016

TSO3 Receives 2017 Purchase Orders from Getinge

December 2, 2016

TSO3 Reports Third Quarter 2016 Results

November 7, 2016

TSO3 to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum on November 17, 2016

October 27, 2016

TSO3 Sets Third Quarter 2016 Conference Call for Monday, November 7, 2016 at 10: 30 a.m. EST

October 25, 2016

TSO3 to Present at the 5th Annual Liolios Gateway Conference on September 7th, 2016

August 24, 2016

TSO3 to Present at Upcoming Investor Conferences

August 4, 2016

TSO3 Reports Second Quarter 2016 Results

August 3, 2016

TSO3 Simplifies Sterilization of Complete Heavy-Duty, Battery-Powered Orthopedic Instrument Sets

July 25, 2016

TSO3 Sets Second Quarter 2016 Conference Call for Wednesday, August 3, 2016 at 10: 30 a.m. EDT

July 20, 2016

TSO3 Prepares for European Product Launch

July 18, 2016

TSO3 Receives U.S. Clearance for Extended Claims for Its Breakthrough Medical Device Sterilizer

July 4, 2016

TSO3 Responds to U.S. Regulators on Extended Claims and Provides Operations Update

June 1, 2016

Canadian Journal of Infection Control to Publish Paper on TSO3's STERIZONE® VP4 Sterilizer

May 18, 2016

TSO3 announces the Results of the Votes from its Annual and Special Meeting of the Shareholders

May 5, 2016

TSO3 Reports Record First Quarter 2016 Results

May 4, 2016

TSO3 to Report First Quarter 2016 Results and Hold Annual General and Special Meeting of Shareholders on Wednesday, May 4, 2016

April 26, 2016

TSO3 to Present at Bloom Burton & Co. Healthcare Investor Conference on May 2, 2016

April 18, 2016

TSO3 Receives FDA 510(k) Clearance for Universal Design of STERIZONE® VP4 Sterilizer

March 28, 2016

TSO3 Reports Fourth Quarter and Full Year 2015 Results

March 23, 2016

TSO3 Provides Update on Extended U.S. Claims Filed for Breakthrough Medical Device Sterilizer

March 14, 2016

TSO3 to Present at the 28th Annual ROTH Conference on March 16, 2016

March 10, 2016

TSO3 Sets Fourth Quarter and Full Year 2015 Earnings Call for Wednesday, March 23, 2016 at 10: 30 a.m. EDT

March 9, 2016

TSO3 Provides Operations Update - Recruiting, Supplier Relationships and Improved Process Flow All Contributing to Increased Production Rates and Shipments

February 25, 2016

TSO3 Announces $13.5 million in Warrant Proceeds

February 8, 2016

TSO3 Appoints Harold R. Tessman as COO

January 27, 2016

TSO3 Accelerates Warrant Expiry Date

January 5, 2016

TSO3 Completes Additional Studies, Files Extended U.S. Claims for Breakthrough Medical Device Sterilizer

December 22, 2015

TSO3 to Expand Manufacturing Workforce to Meet Demand for STERIZONE® VP4 Sterilizer

December 21, 2015

TSO3 Appoints Glen Kayll as Chief Financial Officer

December 18, 2015

← Newer news releases · Older news releases →

Decks

The 5 newest of 41 decks. Every deck is listed under its year.